BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28445235)

  • 1. Recent Trends in the Epidemiology of Hepatocellular Carcinoma in Olmsted County, Minnesota: A US Population-based Study.
    Yang JD; Ahmed Mohammed H; Harmsen WS; Enders F; Gores GJ; Roberts LR
    J Clin Gastroenterol; 2017 Sep; 51(8):742-748. PubMed ID: 28445235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008.
    Yang JD; Kim B; Sanderson SO; St Sauver JL; Yawn BP; Pedersen RA; Larson JJ; Therneau TM; Roberts LR; Kim WR
    Mayo Clin Proc; 2012 Jan; 87(1):9-16. PubMed ID: 22212963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
    Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
    Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
    Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: A nationwide cohort study.
    Hallager S; Ladelund S; Kjaer M; Madsen LG; Belard E; Laursen AL; Gerstoft J; Røge BT; Grønbaek KE; Krarup HB; Christensen PB; Weis N
    J Viral Hepat; 2018 Jan; 25(1):47-55. PubMed ID: 28750141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
    Younossi Z; Stepanova M; Ong JP; Jacobson IM; Bugianesi E; Duseja A; Eguchi Y; Wong VW; Negro F; Yilmaz Y; Romero-Gomez M; George J; Ahmed A; Wong R; Younossi I; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):748-755.e3. PubMed ID: 29908364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
    Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
    J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma: an epidemiologic view.
    El-Serag HB
    J Clin Gastroenterol; 2002; 35(5 Suppl 2):S72-8. PubMed ID: 12394209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
    Perumpail RB; Wong RJ; Ahmed A; Harrison SA
    Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
    Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH
    J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
    Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study.
    Davila JA; Morgan RO; Shaib Y; McGlynn KA; El-Serag HB
    Gastroenterology; 2004 Nov; 127(5):1372-80. PubMed ID: 15521006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-trends in incidence and prognosis of hepatocellular carcinoma in Denmark: A nationwide register-based cohort study.
    Jepsen P; Andersen MW; Villadsen GE; Ott P; Vilstrup H
    Liver Int; 2017 Jun; 37(6):871-878. PubMed ID: 27943604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
    Ascha MS; Hanouneh IA; Lopez R; Tamimi TA; Feldstein AF; Zein NN
    Hepatology; 2010 Jun; 51(6):1972-8. PubMed ID: 20209604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study.
    Alavi M; Janjua NZ; Chong M; Grebely J; Aspinall EJ; Innes H; Valerio H; Hajarizadeh B; Hayes PC; Krajden M; Amin J; Law MG; George J; Goldberg DJ; Hutchinson SJ; Dore GJ
    J Viral Hepat; 2018 May; 25(5):473-481. PubMed ID: 29194861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States.
    Kim D; Li AA; Perumpail BJ; Gadiparthi C; Kim W; Cholankeril G; Glenn JS; Harrison SA; Younossi ZM; Ahmed A
    Hepatology; 2019 Mar; 69(3):1064-1074. PubMed ID: 30014489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
    Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
    Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.
    Kim GA; Lee HC; Kim MJ; Ha Y; Park EJ; An J; Lee D; Shim JH; Kim KM; Lim YS
    J Hepatol; 2015 May; 62(5):1092-9. PubMed ID: 25445399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres.
    Cazzagon N; Trevisani F; Maddalo G; Giacomin A; Vanin V; Pozzan C; Poggio PD; Rapaccini G; Nolfo AM; Benvegnù L; Zoli M; Borzio F; Giannini EG; Caturelli E; Chiaramonte M; Foschi FG; Cabibbo G; Felder M; Ciccarese F; Missale G; Baroni GS; Morisco F; Pecorelli A; Farinati F;
    Liver Int; 2013 Oct; 33(9):1420-7. PubMed ID: 23758775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.